We provide you with 20 years of free, institutional-grade data for SANA stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of SANA. Explore the full financial landscape of SANA stock.
Reported Date | CIK | Ticker | Type | |
---|---|---|---|---|
2025-08-11 | 0001770121 | SANA | 10-Q | Url |
2025-05-08 | 0001770121 | SANA | 10-Q | Url |
2025-03-17 | 0001770121 | SANA | 10-K | Url |
2024-11-08 | 0001770121 | SANA | 10-Q | Url |
2024-08-08 | 0001770121 | SANA | 10-Q | Url |
2024-05-08 | 0001770121 | SANA | 10-Q | Url |
2024-02-29 | 0001770121 | SANA | 10-K | Url |
2023-11-08 | 0001770121 | SANA | 10-Q | Url |
2023-08-03 | 0001770121 | SANA | 10-Q | Url |
2023-05-08 | 0001770121 | SANA | 10-Q | Url |
2023-03-16 | 0001770121 | SANA | 10-K | Url |
2022-11-02 | 0001770121 | SANA | 10-Q | Url |
2022-08-04 | 0001770121 | SANA | 10-Q | Url |
2022-05-10 | 0001770121 | SANA | 10-Q | Url |
2022-03-16 | 0001770121 | SANA | 10-K | Url |
2021-11-08 | 0001770121 | SANA | 10-Q | Url |
2021-08-04 | 0001770121 | SANA | 10-Q | Url |
2021-05-05 | 0001770121 | SANA | 10-Q | Url |
2021-03-24 | 0001770121 | SANA | 10-K | Url |
2021-01-13 | 0001770121 | SANA | S-1 | Url |
Sana Biotechnology, Inc(NASDAQ:SANA)


Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops in vivo and ex vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiov...
Share this website to your friends
The information provided in this report about SANA stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.